November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Myeloma Paper of the Day, July 13th, suggested by Robert Orlowski
Jul 13, 2024, 04:43

Myeloma Paper of the Day, July 13th, suggested by Robert Orlowski

Robert Orlowski shared on X:

Myeloma Paper of the Day: Study comparing Monoclonal Gammopathy of Undetermined Significance (MGUS) prevalence in Eswatini vs. Olmsted County finds incidence similar between ethnicities & raises question of whether current definition of light-chain MGUS may be capturing alternate etiologies, such as HIV”

Source: Robert Orlowski/X

Prevalence of monoclonal gammopathy of undetermined significance in Eswatini: a Population-Based study in Africa

Authors: Kara I Cicero, Xolisile Dlamini, Yvonne Mavengere, Jessica Justman, Harriet Nuwagaba-Biribonwoha, Sindisiwe Dlamini, Mxolisi Dlamini, Simphiwe Ngwenyama, Cebisile Ngcamphalala, Andrea Low, Neena M Philip, Wafaa M El-Sadr, Ruben Sahabo, Tesfay Abreha, Sintayehu Temesgen, Nokuthula Mahlalela, Codruta Chiuzan, Yuxuan Chen, Samuel S Pan, Suzanne Lentzsch, Alfred I Neugut 

Myeloma Paper of the Day, July 13th, suggested by Robert Orlowski

Other posts featuring Robert Orlowski on OncoDaily.

Robert Orlowski holds multiple positions at The University of Texas MD Anderson Cancer Center, including Chairman, Ad Interim Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics within the Division of Cancer Medicine.

Additionally, he chairs the SWOG Barlogie/Salmon Myeloma Committee, which is part of the National Clinical Trials Network, dedicated to advancing new therapies and understanding the biology of myeloma.